Taking into account the complexity and limitations of clinical assessment in hypertrophic
cardiomyopathy (HCM), imaging techniques play an essential role in the evaluation of …

Hypertrophic cardiomyopathy (HCM) is characterized by substantial genetic and phenotypic
heterogeneity, leading to considerable diversity in clinical course including the most …

Kardiomiopatie definiuje się jako strukturalne oraz funkcjonalne nieprawidłowości mięśnia
komór, które nie wynikają z niedokrwienia na skutek choroby wieńcowej czy …

Since its original description 50 years ago, myocardial ischemia has been a recognized but
underappreciated aspect of the pathophysiology of hypertrophic cardiomyopathy (HCM) …

Hypertrophic cardiomyopathy (HCM) is the most common genetic disease of the heart. HCM
is characterized by a wide range of clinical expression, ranging from asymptomatic mutation …

Two distinct types of left ventricular hypertrophy (LVH) have been described: the so called
“physiologic” hypertrophy, which is normally found in professional athletes, and “pathologic” …

Hypertrophic cardiomyopathy (HCM) is defined by the presence of left ventricular
hypertrophy in the absence of other potentially causative cardiac, systemic, syndromic, or …

Background Microvascular dysfunction in HCM has been associated with adverse clinical
outcomes. Advances in quantitative cardiovascular magnetic resonance (CMR) perfusion …

Dilated cardiomyopathy (DCM) represents the final common morphofunctional pathway of
various pathological conditions in which a combination of myocyte injury and necrosis …

Objectives Distinguishing hypertrophic cardiomyopathy (HCM) from left ventricular
hypertrophy (LVH) due to systematic training (athlete's heart, AH) from morphologic …